Skip header and navigation

Narrow By

   MORE

4 records – page 1 of 1.

Cancer Screening in Inflammatory Bowel Disease : A Guide to Risk Management and Techniques

https://libcat.nshealth.ca/en/permalink/provcat44388
Joseph D. Feuerstein, Adam S. Cheifetz, editors. --Cham: Springer , c2019.
Available Online
View e-Book
Location
Online
This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging dru…
Available Online
View e-Book
Other Authors
Feuerstein, Joseph D.
Cheifetz, Adam S.
Responsibility
Joseph D. Feuerstein, Adam S. Cheifetz, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2019
Physical Description
1 online resource (xi, 174 p.) : 14 illus. in color
ISBN
9783030153014
9783030153007 (Print ed.)
9783030153021 (Print ed.)
9783030153038 (Print ed.)
Subjects (MeSH)
Colorectal Neoplasms - diagnosis
Inflammatory Bowel Diseases - complications
Risk Factors
Specialty
Gastroenterology
Medical Oncology
Abstract
This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.
Contents
Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy.
Format
e-Book
Location
Online
Less detail

Golimumab (SimponiĀ®) for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35651
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1641
Available Online
View Pamphlet
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Golimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Golimumab (Simponi) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1641
Less detail

Inflammatory Bowel Disease and Familial Adenomatous Polyposis : Clinical Management and Patients' Quality of Life

https://libcat.nshealth.ca/en/permalink/provcat29444
edited by Gian Gaetano Delaini. --Milan: Springer-Verlag Italia , c2006.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Delaini, Gian Gaetano
Responsibility
edited by Gian Gaetano Delaini
Place of Publication
Milan
Publisher
Springer-Verlag Italia
Date of Publication
c2006
ISBN
9788847004344
Subjects (MeSH)
Adenomatous Polyposis Coli - therapy
Inflammatory Bowel Diseases - complications
Inflammatory Bowel Diseases - diagnosis
Inflammatory Bowel Diseases - therapy
Subjects (LCSH)
Colorectal diseases
Format
e-Book
Location
Online
Less detail

Interventional inflammatory bowel diseases

https://libcat.nshealth.ca/en/permalink/provcat50847
Shen, Bo. (1st ed.) --Philadelphia, PA: Elsevier , 2018.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Shen, Bo
Edition
1st ed.
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
2018
ISBN
9780128113882
Subjects (MeSH)
Endoscopy, Gastrointestinal
Inflammatory Bowel Diseases - complications
Inflammatory Bowel Diseases - surgery
Inflammatory Bowel Diseases - therapy
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail